Related Experiment Video
Updated: May 11, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Decoding bronchopulmonary dysplasia in premature infants through an epigenetic lens
Seyed Alireza Dastgheib1, Reza Bahrami2, Mohammad Golshan-Tafti3
1Department of Medical Genetics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Epigenetic changes like DNA methylation and RNA regulation are key in bronchopulmonary dysplasia (BPD) development in premature infants. These alterations offer potential biomarkers for early detection and targeted interventions for BPD.
Area of Science:
- Neonatal Medicine
- Epigenetics
- Pulmonary Biology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants resulting from complex genetic and environmental factors.
- Epigenetic mechanisms, including DNA methylation, histone modifications, and RNA regulation, are increasingly recognized as crucial in BPD pathogenesis.
- Understanding these epigenetic alterations is vital for developing effective diagnostic and therapeutic strategies.
Purpose of the Study:
- To provide a comprehensive review of the epigenetic mechanisms implicated in the development of bronchopulmonary dysplasia (BPD).
- To highlight the roles of DNA methylation, histone modifications, and various RNA species in BPD.
- To explore the potential of epigenetic alterations as biomarkers and therapeutic targets for BPD.
Main Methods:
- Review of current literature on epigenetic mechanisms in BPD.
- Analysis of studies investigating DNA methylation, histone modifications, and RNA regulation (m6A, microRNAs, lncRNAs) in the context of BPD.
- Identification of key genes and pathways affected by epigenetic changes.
Main Results:
- Intrauterine and neonatal factors (hypoxia, hyperoxia, nutrition) induce epigenetic alterations impacting gene expression.
- RUNX3 identified as a critical transcription factor in lung development and inflammation.
- Epigenetic changes in cord blood, including DNA methylation and histone dynamics, are linked to immune dysregulation in BPD.
- Specific RNA regulators (IGF2BP family, miR-17∼92 cluster, MALAT1 lncRNA) influence mRNA stability, gene expression, and vascular regulation relevant to BPD.
Conclusions:
- Epigenetic mechanisms play a significant role in the pathogenesis of BPD.
- Epigenetic alterations present potential biomarkers for early BPD detection and risk assessment.
- Targeted epigenetic interventions may offer novel therapeutic strategies to reduce BPD severity and improve outcomes for neonates.
Abstract:
This review provides a comprehensive overview of the evolving insights into the epigenetic mechanisms associated with bronchopulmonary dysplasia (BPD). It specifically highlights the roles of DNA methylation, histone modifications, and RNA regulation in the development of BPD in premature infants. BPD results from complex interactions among genetic factors, environmental exposures, and neonatal stressors. Key findings suggest that intrauterine hypoxia, hyperoxia, and nutrition can lead to epigenetic alterations, affecting gene expression and methylation, which may serve as biomarkers for early BPD detection. RUNX3 is identified as a critical transcription factor influencing lung development and inflammation, while changes in DNA methylation and histone dynamics in cord blood are linked to immune dysregulation associated with BPD. The role of m6A RNA methylation regulators from the IGF2BP family affects mRNA stability and gene expression relevant to BPD. Additionally, specific histones and microRNAs, particularly from the miR-17∼92 cluster, are implicated in pulmonary development and vascular regulation. Long non-coding RNAs (lncRNAs), such as MALAT1, also play a role in gene regulation via competitive endogenous RNA networks, indicating their potential as biomarkers and therapeutic targets. The interplay of these epigenetic mechanisms underscores the need for further research to develop targeted interventions aimed at reducing BPD severity and enhancing health outcomes for at-risk neonates.
Related Concept Videos
Epigenetic Regulation
Breathing
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Gene-Environment Interactions

